2015 Lipper Award
Janus Contrarian Fund (JSVAX)
Investing Opportunistically in Non-Consensus Equity Ideas

SHARE CLASS

FUND FACTS (JSVAX)

Inception Date2/29/2000
NAV (As of 4/17/15 )$21.94
Total Net Assets (As of 3/31/15)$4.57B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.89%
NET 0.89%

Performance (As of 3/31/15)
1 Year12.71%
3 Year20.78%
5 Year11.90%
10 Year9.32%
Morningstar (As of 3/31/15)
CategoryLarge Blend
Equity
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/16.

Data as of 3/31/15. Index represents the S&P 500® Index.

TOP HOLDINGS (% of Fund)

Endo International PLC 8.76
United Continental Holdings, Inc. 8.44
Mallinckrodt PLC 6.94
Air Products & Chemicals, Inc. 4.90
Motorola Solutions, Inc. 4.88
St Joe Co. 4.24
Knowles Corp. 3.32
Dollar Tree, Inc. 3.25
Citigroup, Inc. 3.13
E*TRADE Financial Corp. 3.06
TOTAL50.92

CHARACTERISTICS

Number of Holdings
Equity Issues

47
Market Capitalization
Weighted Average
Median

$33.67B
$14.65B
Portfolio Turnover Ratio
(1-year trailing)

58.92%
Price/Earnings Ratio
(1-year forward)

18.67
Price/Book Ratio
(1-year forward)

4.16
Earnings Growth Rate
(1-year forward)

4.47%

MONTHLY TOP EQUITY
CONTRIBUTORS & DETRACTORS

CONTRIBUTORS
Herbalife, Ltd.
Mallinckrodt PLC
Endo International PLC
St Joe Co.
United Continental Holdings, Inc.
DETRACTORS
Rayonier Advanced Materials, Inc.
Colfax Corp.
Microsoft Corp.
ITC, Ltd.
Air Products & Chemicals, Inc.

SECTOR ALLOCATION (%)

FUND INDEX 
Health Care 18.77 14.93
 
 
Information Technology 15.11 19.68
 
 
Financials 15.09 16.21
 
 
Consumer Discretionary 15.02 12.60
 
 
Industrials 12.86 10.37
 
 
Materials 10.28 3.16
 
 
Energy 6.13 8.04
 
 
Consumer Staples 5.29 9.69
 
 
Cash & Equivalents 1.41 -
 
Restricted Cash 0.04 -
 

DEVELOPED VS. EMERGING MARKET EXPOSURE (%)

FUNDINDEX
U.S. 95.78 99.97
Non-U.S. Emerging 1.69 -
Non-U.S. Developed 1.08 0.03
Restricted Cash 0.04 -
Cash & Equivalents 1.41 -

REGIONS (%)

FUNDINDEX
North America 95.78 99.97
Asia/Pacific Ex Japan 1.69 -
Europe 1.08 0.03
Cash & Equivalents 1.41 -
Restricted Cash 0.04 -

MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS (%)

FUNDINDEX
Over $100 Billion 9.56 42.94
$10 Billion to $50 Billion 52.01 34.42
$5 Billion to $10 Billion 13.29 3.69
$1 Billion to $5 Billion 23.05 0.42
$500 Million to $1 Billion 0.92 -
N/A 1.17 -

Equity country, regional, sector and industry weights based on MSCI and GICS classifications. Fixed income country, regional, sector and industry weights based on Barclays classifications.